Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season

Journal of Infectious Diseases

Volumn 186, Issue 10, 2002, Pages 1490-1493

  Xu, Xiyan ^a   Smith, Catherine B ^a   Mungall, Bruce A ^a   Lindstrom, Stephen E ^a   Hall, Henrietta E ^a   Subbarao, Kanta ^a   Cox, Nancy J ^a   Klimov, Alexander ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CONTROLLED STUDY; EGYPT; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALAYSIA; NUCLEOTIDE SEQUENCE; OMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGAPORE; UNITED STATES; VACCINATION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTIGENS, VIRAL; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; NEURAMINIDASE; REASSORTANT VIRUSES;

EID: 0037111035     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344738     Document Type: Article

References (15)

1. Yamane N, Arikawa J, Odigiri T. Isolation of three different influenza A viruses from an individual after probable double infection with H3N2 and H1N1 viruses. Jpn J Med Sci Biol 1978;31:431-4.
2. Xu X, Rocha EP, Regnery HL, Kendal AP, Cox NJ. Genetic and antigenic analysis of influenza A (H1N1) viruses, 1986-1991. Virus Res 1993;28:37-55.
3. Bean WJ, Cox NJ, Kendal AP. Recombination of human influenza A viruses in nature. Nature 1980;284:638-40.
4. Nishikawa F, Sugiyama T. Direct isolation of H1N2 recombinant virus from a throat swab of a patient simultaneously infected with H1N1 and H3N2 influenza A viruses. J Clin Microbiol 1983;18:425-7.
5. Guo YJ, Xu X, Cox NJ. Human influenza A (H1N2) viruses isolated from China. J Gen Virol 1992;73:383-8.
6. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2002-2003 season. Wkly Epidemiol Rec 2002;77:62-6.
7. Kendal AP, Skehel JJ, Pereira MS. Concepts and Procedures for Laboratory-based Influenza Surveillance. Atlanta: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1982.
8. Aymard-Henry M, Coleman MT, Dowdle WR, Laver WG, Schild GC, Webster RG. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ 1973;48:199-202.
9. Devereaux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for VAX. Nucleic Acid Res 1984;12:387:395.
10. Felsenstein J. PHYLIP - Phylogeny inference package (version 3.2). Cladistics 1989;5:164-6.
11. Cooper LA, Subbarao K. A simple restriction fragment length polymorphism-based strategy that can distinguish the internal genes of human H1N1, H3N2, and H5N1 influenza A viruses. J Clin Microbiol 2000;38:2579-83.
12. Weis W, Brown JH, Cusack S. Paulson JC, Skehel JJ, Wiley DD. Structure of the influenza virus hemagglutinin complex with its receptor, sialic acid. Nature 1988;333:426-31.
13. Canton A, Brownlee GG, Yewdell JW. Gerhard W. The antigenic structure of the influenza virus A/PR/*/34 hemagglutinin (H1 subtype). Cell 1982;31:417-27.
14. World Health Organization. Influenza A (H1N2) viruses (update). Wkly Epidemiol Rec 2002;77:77-80.
15. Centers for Disease Control and Prevention. Update: Influenza activity - United States, 2002 season. MMWR Morb Mortal Wkly Rep 2002;51:78-80.